Image Credit: STAT News
Opinion: STAT+: Bristol Myers Squibb CEO: Pharmaceutical innovation requires bold yet predictable U.S. policy
Bristol Myers Squibb CEO warns against “slashing U.S. investment in medicines or importing lackluster policies of less innovative health care systems.”